A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Why the study?
Does the HAS-BLED score accurately assess the 1-year risk of major bleeding in patients with atrial fibrillation?
Population
Patients with atrial fibrillation (AF)
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
May aid AF bleeding risk assessment; leaves open need for prospective validation before practice change.
Key Points
- This research aims to develop a user-friendly score (HAS-BLED) to evaluate the risk of major bleeding in patients with atrial fibrillation.
- Developed a novel bleeding risk score called HAS-BLED
- Assessed its efficacy in real-world clinical settings
- Utilized standard risk factors for bleeding assessment
- HAS-BLED score effectively identifies patients at high risk of major bleeding
- Improves clinical decision making regarding antithrombotic therapy
- Demonstrated strong predictive value over traditional methods
Structured PICO
Does the HAS-BLED score accurately assess the 1-year risk of major bleeding in patients with atrial fibrillation?
P
Population
Patients with atrial fibrillation (AF)
I
Intervention
HAS-BLED bleeding risk score
O
Outcome
1-year risk of major bleedingsafety
The novel HAS-BLED score provides a practical tool to assess individual 1-year major bleeding risk in real-world patients with atrial fibrillation, supporting clinical decision-making for antithrombotic therapy.
Cite This Study
Pisters et al. (2010) studied this question.